Biocytogen boston corp:1375719 24-001992 FOS-T2A-ICREERT2 knockin sprague dawley RAT
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00155
- Awardee
-
Biocytogen Boston Corp UEI SN23DNZQQTF9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,100
Award facts
- Contract value 100% obligated
- $13,100.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
About this award
Biocytogen Boston Corporation was awarded a firm fixed price purchase order valued at thirteen thousand one hundred dollars by the National Institutes of Health's National Institute on Drug Abuse. The contract is for the delivery of FOS-T2A-ICREERT2 knockin Sprague Dawley rats to the agency's facilities in Baltimore, Maryland. No set-aside designation was applied to this procurement. Work under the contract is to be completed by February 21, 2025.
Quick answers
Who was awarded contract 75N95024P00155?
75N95024P00155 was awarded to Biocytogen Boston Corp by National Institute on Drug Abuse (National Institutes of Health) on February 22, 2024.
How much is contract 75N95024P00155 worth?
The government has obligated $13,100 on 75N95024P00155.
Was contract 75N95024P00155 competed?
The extent of competition for 75N95024P00155 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award